comparemela.com
Home
Live Updates
Review of the NLRP3 Inflammasome Inhibitor RRx-001 Published
Review of the NLRP3 Inflammasome Inhibitor RRx-001 Published
Review of the NLRP3 Inflammasome Inhibitor RRx-001 Published in the Prestigious Scientific Journal, Drugs
/PRNewswire/ -- EpicentRx Inc. ("EpicentRx"), a clinical stage biopharmaceutical company, announced today the publication of a review article on its small...
Related Keywords
Australia ,
Richard Gordon ,
Nanthini Jayabalan ,
Translational Research Institute ,
Michaelj Fox Foundation ,
Epicentrx Inc ,
Shake It Up Australia Foundation ,
Late Stage Multi Indication Inhibitor ,
Associate Professor Richard Gordon ,
Queensland University ,
Microbiome Research ,
Amyotrophic Lateral Sclerosis ,
Epicentrx ,
Nc ,